Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dentsply Sirona (XRAY) Cash & Equivalents (2016 - 2025)

Dentsply Sirona (XRAY) has disclosed Cash & Equivalents for 17 consecutive years, with $326.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash & Equivalents rose 19.85% year-over-year to $326.0 million, compared with a TTM value of $326.0 million through Dec 2025, up 19.85%, and an annual FY2025 reading of $326.0 million, up 19.85% over the prior year.
  • Cash & Equivalents was $326.0 million for Q4 2025 at Dentsply Sirona, down from $363.0 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $418.0 million in Q3 2022 and bottomed at $272.0 million in Q4 2024.
  • Average Cash & Equivalents over 5 years is $331.4 million, with a median of $329.0 million recorded in 2021.
  • The sharpest move saw Cash & Equivalents plummeted 77.91% in 2021, then skyrocketed 48.75% in 2022.
  • Year by year, Cash & Equivalents stood at $339.0 million in 2021, then grew by 7.67% to $365.0 million in 2022, then dropped by 8.49% to $334.0 million in 2023, then dropped by 18.56% to $272.0 million in 2024, then increased by 19.85% to $326.0 million in 2025.
  • Business Quant data shows Cash & Equivalents for XRAY at $326.0 million in Q4 2025, $363.0 million in Q3 2025, and $359.0 million in Q2 2025.